[Federal Register Volume 84, Number 69 (Wednesday, April 10, 2019)]
[Notices]
[Pages 14396-14397]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07047]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-1075]


Certain Electrochemical Glucose Monitoring Systems and Components 
Thereof; Commission Determination To Affirm an Initial Determination 
Granting a Motion for Summary Determination of Non-Infringement of the 
Asserted Patents; Termination of Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined to affirm an initial determination (Order No. 
33) granting a motion for summary determination of non-infringement of 
the asserted patents and the presiding administrative law judge's 
(``ALJ'') underlying orders. The investigation is terminated.

FOR FURTHER INFORMATION CONTACT: Megan M. Valentine, Office of the 
General Counsel, U.S. International Trade Commission, 500 E Street SW,

[[Page 14397]]

Washington, DC 20436, telephone 202-708-2301. Copies of non-
confidential documents filed in connection with this investigation are 
or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW, Washington, DC 20436, 
telephone 202-205-2000. General information concerning the Commission 
may also be obtained by accessing its internet server (https://www.usitc.gov). The public record for this investigation may be viewed 
on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. 
Hearing-impaired persons are advised that information on this matter 
can be obtained by contacting the Commission's TDD terminal on 202-205-
1810.

SUPPLEMENTARY INFORMATION: The Commission instituted this investigation 
on October 25, 2017, based on a complaint filed on September 18, 2017, 
on behalf of Dexcom, Inc. of San Diego, California (``Dexcom''). 82 FR 
49420 (Oct. 25, 2017). The complaint alleges violations of section 337 
of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, based upon the 
importation into the United States, the sale for importation, and the 
sale within the United States after importation of certain 
electrochemical glucose monitoring systems and components thereof by 
reason of infringement of one or more of claims of U.S. Patent Nos. 
9,724,045 and 9,750,460. The notice of investigation named as a 
respondent AgaMatrix, Inc. of Salem, New Hampshire (``AgaMatrix''). The 
Office of Unfair Import Investigations was not named as a party in the 
investigation.
    On May 10, 2018, the ALJ issued Order No. 26, granting-in-part a 
motion by AgaMatrix to strike portions of Dexcom's expert reports. 
Order No. 26 struck, in relevant part, certain portions of an expert 
report relating to whether the accused products meet the ``film'' term 
of the ``enzyme-containing film'' limitation of the asserted claims and 
precluded Dexcom from relying on the arguments and theories described 
in the struck portions of the expert report during the investigation.
    On May 17, 2018, AgaMatrix filed a motion for summary determination 
of non-infringement of the asserted patents on the basis that Dexcom 
cannot prove that the accused products directly or indirectly infringe 
any of the asserted claims. On May 29, 2018, Dexcom opposed the motion. 
On June 1, 2018, AgaMatrix moved for leave to file a reply in support 
of its motion. On June 6, 2018, Dexcom opposed the motion for leave.
    On June 7, 2018, the ALJ issued the subject initial determination 
(``ID'') (Order No. 33), granting AgaMatrix's motion for summary 
determination of non-infringement with respect to direct infringement 
but denying the motion with respect to indirect infringement. The ID 
also denied AgaMatrix's motion for leave to file a reply in support of 
its motion and stayed the procedural schedule pending review of the ID.
    On June 18, 2018, Dexcom filed a petition for review of the ID's 
findings on direct infringement and Order No. 26. On June 25, 2018, 
AgaMatrix filed its opposition.
    On July 23, 2018, the Commission determined to review the subject 
ID in its entirety, as well as the underlying orders. Notice (July 23, 
2018).
    Having reviewed the record in this investigation, including the 
subject ID, the petition for review, and response thereto, the 
Commission has determined to affirm Order No. 33's summary 
determination of non-infringement and the ALJ's underlying orders. 
Commissioner Schmidtlein dissents from the majority's decision. Her 
views have been filed on EDIS.
    The investigation is terminated.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in part 210 of the Commission's Rules of Practice and Procedure (19 CFR 
part 210).

    By order of the Commission.

    Issued: April 4, 2019.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2019-07047 Filed 4-9-19; 8:45 am]
 BILLING CODE 7020-02-P